Chemotherapy use was also numerically lower during the COVID period, although this difference did not reach statistical significance (70.3% vs. 71.9%, p = 0.087) ( Table 1 and Figure 2 ). 3.2.
← all excerpts
Survival Outcomes and Machine Learning-Based Prediction of 12-Month Mortality in Glioblastoma Before and During the COVID-19 Pandemic: A SEER Population-Based Study.
1
0.0870
0.0870